High-dose glucocorticoids increases the expression of mineralocorticoid receptor in vascular endothelial cells

European Review for Medical and Pharmacological Sciences

Volumn 19, Issue 22, 2015, Pages 4314-4323

  Wang, X Y ^a   Chen, X L ^a   Wang, L ^a   Chen, H W ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Glucocorticoid; Glucocorticoid receptor; Mineralocorticoid receptor

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; LIPOPOLYSACCHARIDE; MESSENGER RNA; MINERALOCORTICOID RECEPTOR;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR ENDOTHELIAL CELL; VASCULAR ENDOTHELIUM; AGONISTS; BIOSYNTHESIS; DOSE RESPONSE; DRUG EFFECTS; GENE EXPRESSION REGULATION; METABOLISM; UPREGULATION;

DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LIPOPOLYSACCHARIDES; RECEPTORS, GLUCOCORTICOID; RECEPTORS, MINERALOCORTICOID; UP-REGULATION;

EID: 84957974978     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. SUNTHARALINGAM M. Definitive chemoradiation in the management of locally advanced esophageal cancer. Semin Radiat Oncol 2007; 17: 22-28.
2. BRESLIN MB, GENG CD, VEDECKIS WV. Multiple promoters exist in the human GR gene, one of which is activated by glucocorticoids. Mol Endocrinol 2001; 15: 1381-1395.
3. ROGERSON FM, BRENNAN FE, FULLER PJ. Mineralocorticoid receptor binding, structure and function. Mol Cell Endocrinol 2004; 217: 203-212.
4. SON Y, LEE JH, CHEONG YK, JUNG HC, JEONG SO, PARK SH, PAE HO. Piceatannol, a natural hydroxylated analog of resveratrol, promotes nitric oxide release through phosphorylation of endothelial nitric oxide synthase in human endothelial cells. Eur Rev Med Pharmacol Sci 2015; 19: 3125-3132.
5. KROZOWSKI Z. The 11beta-hydroxysteroid dehydrogenases: functions and physiological effects. Mol Cell Endocrinol 1999; 151: 121-127.
6. BLAND R, WORKER CA, NOBLE BS, EYRE LJ, BUJALSKA IJ, SHEPPARD MC, STEWART PM, HEWISON M. Characterization of 11beta-hydroxysteroid dehydrogenase activity and corticosteroid receptor expression in human osteosarcoma cell lines. J Endocrinol 1999; 161: 455-464.
7. SUZUKI T, SASANO H, KANEKO C, OGAWA S, DARNEL AD, KROZOWSKI ZS. Immunohistochemical distribution of 11beta-hydroxysteroid dehydrogenase in human eye. Mol Cell Endocrinol 2001; 173: 121-125.
8. WANG JY, GUO JS, LI H, LIU SL, ZERN MA. Inhibitory effect of glycyrrhizin on NF-kappaB binding activity in CCl4- plus ethanol-induced liver cirrhosis in rats. Liver 1998; 18: 180-185.
9. WANG J, ZHAO J, LI J, WANG F, SU Y. Time-course changes in nuclear translocation of hepatic glucocorticoid receptor in rats after burn trauma and its pathophysiological significance. Shock 2008; 30: 747-752.
10. UDELSMAN R, HOLBROOK NJ. Endocrine and molecular responses to surgical stress. Curr Probl Surg 1994; 31: 653-720.
11. GOLIER J, YEHUDA R. Neuroendocrine activity and memory-related impairments in posttraumatic stress disorder. Dev Psychopathol 1998; 10: 857-869.
12. MATHIEU M, GOUGAT C, JAFFUEL D, DANIELSEN M, GODARD P, BOUSQUET J, DEMOLY P. The glucocorticoid receptor gene as a candidate for gene therapy in asthma. Gene Ther 1999; 6: 245-252.
13. HERMAN JP, SPENCER R. Regulation of hippocampal glucocorticoid receptor gene transcription and protein expression in vivo. J Neurosci 1998; 18: 7462-7473.
14. COLE MA, KIM PJ, KALMAN BA, SPENCER RL. Dexamethasone suppression of corticosteroid secretion: evaluation of the site of action by receptor measures and functional studies. Psychoneuroendocrinology 2000; 25: 151-167.
15. OKAMOTO K, TANAKA H, OGAWA H, MAKINO Y, EGUCHI H, HAYASHI S, YOSHIKAWA N, POELLINGER L, UMESONO K, MAKINO I. Redox-dependent regulation of nuclear import of the glucocorticoid receptor. J Biol Chem 1999; 274: 10363-10371.
16. FAN J, GONG XQ, WU J, ZHANG YF, XU RB. Effect of glucocorticoid receptor (GR) blockade on endotoxemia in rats. Circ Shock 1994; 42: 76-82.
17. LIU DH, SU YP, ZHANG W, LOU SF, GAO JS, CHENG TM. [Changes in aldosterone binding activity of kidney cytosol after stress in rats and the regulation]. Sheng Li Xue Bao 2001; 53: 375-379.
18. PERLSTEIN RS, WHITNALL MH, ABRAMS JS, MOUGEY EH, NETA R. Synergistic roles of interleukin-6, interleukin- 1, and tumor necrosis factor in the adrenocorticotropin response to bacterial lipopolysaccharide in vivo. Endocrinology 1993; 132: 946-952.
19. MASTORAKOS G, CHROUSOS GP, WEBER JS. Recombinant interleukin-6 activates the hypothalamic-pituitary- adrenal axis in humans. J Clin Endocrinol Metab 1993; 77: 1690-1694.
20. AKIRA S, HIRANO T, TAGA T, KISHIMOTO T. Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). Faseb J 1990; 4: 2860-2867.
21. FISCHER JE, HASSELGREN PO. Cytokines and glucocorticoids in the regulation of the "hepato-skeletal muscle axis" in sepsis. Am J Surg 1991; 161: 266-271.
22. BONDESON J, BROWNE KA, BRENNAN FM, FOXWELL BM, FELDMANN M. Selective regulation of cytokine induction by adenoviral gene transfer of Ikappa- Balpha into human macrophages: lipopolysaccharide- induced, but not zymosan-induced, proinflammatory cytokines are inhibited, but IL-10 is nuclear factor-kappaB independent. J Immunol 1999; 162: 2939-2945.
23. EPSTEIN M. Aldosterone as a mediator of progressive renal dysfunction: evolving perspectives. Intern Med 2001; 40: 573-583.
24. MIRIC G, DALLEMAGNE C, ENDRE Z, MARGOLIN S, TAYLOR SM, BROWN L. Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin- diabetic rats. Br J Pharmacol 2001; 133: 687-694.
25. SECKL JR. 11beta-hydroxysteroid dehydrogenases: changing glucocorticoid action. Curr Opin Pharmacol 2004; 4: 597-602.
26. JOELS M, DE KLOET ER. Mineralocorticoid and glucocorticoid receptors in the brain. Implications for ion permeability and transmitter systems. Prog Neurobiol 1994; 43: 1-36.
27. DIAZ R, BROWN RW, SECKL JR. Distinct ontogeny of glucocorticoid and mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase types I and II mRNAs in the fetal rat brain suggest a complex control of glucocorticoid actions. J Neurosci 1998; 18: 2570-2580.